The effect of granulocyte colony-stimulating factor on oral mucositis in head and neck cancer patients treated with hyperfractionated radiotherapy

Oral Oncology

Volumn 35, Issue 2, 1999, Pages 203-208

  Mascarin, Maurizio ^a   Franchin, Giovanni ^a   Minatel, Emilio ^a   Gobitti, Carlo ^a   Talamini, Renato ^a   De Maria, Dario ^b   Trovò, Mauro G ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Granulocyte colony stimulating factor; Head and neck cancer; Mucositis; Radiation mucositis

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; DRUG COST; DRUG EFFECT; FEMALE; HEAD AND NECK CANCER; HIGH RISK PATIENT; HUMAN; MALE; MOUTH MUCOSA; MUCOSA INFLAMMATION; PARENTERAL NUTRITION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT REDUCTION;

EID: 0032997649     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(98)00090-6     Document Type: Article

References (33)

1. Cooper JS, Fu K, Marks J, Silvermann S. Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys 1995;31:1141-64.
2. Martin MV. Irradiation mucositis: a reappraisal. Oral Oncol Eur J Cancer 1993;29B:1-2.
3. Van Saene HKF, Martin MV. Do micro-organism play a role in irradiation mucositis? Eur J Clin Microbiol Infect Dis, 1990;9:861-3.
4. Meurman JH, Pyrhönen S, Teerenhovi L, Lindqvist C. Oral sources of septicaemia in patients with malignancies. Oral Oncol 1997;33(6):389-97.
5. Teir H, Rytomaa T, Cedeberg A, Kiviniemi K. Studies on the elimination of granulocytes in the intestinal tract of the rat. Acta Pathol Microb Scand 1963;59:311-24.
6. Wright DG, Maierovics AI, Foxley JM. Assessing the delivery of neutrophils to tissues in neutropenia. Blood 1986;67:1023-1030.
7. Kenny SA. Effect of two oral care protocols on the incidence of stomatitis in hematology patients. Cancer Nursing 1990;13:345-53.
8. Lieschke GJ, Ramenghi U, O'Connor MP, Sheridan W, Szer J, Morstyn G. Studies of oral neutrophil levels in patients receiving G-CSF after autologous marrow transplantation. Br J Haematol 1992;82:589-95.
9. Fushiki M, Abe M. Randomized double-blinded controlled study of rhG-CSF in patients with neutropenia induced by radiation therapy. Proc Am Soc Clin Oncol 1992;11:410 (abstr 1437).
10. Schmidberger H, Hess CF, Hoffmann W. Reuss-Borst M.A., Bamberg M. Granulocyte colony-stimulating factor treatment of leucopenia during fractionated radiotherapy. Eur J Cancer 1993;29A:1927-31.
11. Janssens P, Mitine C, Beaduin M, Scalliet P. Is there potential for granulocyte or granulocye-macrophage colony stimulating factors in radiotherapy? Eur J Cancer 1994;30A:642-5.
12. Knox SJ, Flowler S, Marquez C, Hoppe RT. Effect of filgastrim (G-CSF) in Hodgkin disease patients treated with radiation therapy. Int J Radiat Oncol Biol Phys 1993;28:445-50.
13. Gabrilove J, Jakubowski A, Scher H, et al. Effect of granulocyte colony-stimulating factors on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 1988;318:1414-22.
14. Cascinu S, Fedeli A, Luzi Fedeli S, Catalano G. Intensive weekly chemotherapy for advanced gastric cancer using 5-fluorouracil, epi-doxorubicin, 6S-leucoverin and granulocyte-colony stimulating factor. Int J Oncol 1993;3:535-8.
15. Ho AD, Del Valle F, Engelhard M, et al. Mitoxantrone/high dose Ara-C and recombinant human GM-CSF in the treatment of refractory non-Hodgkin's lymphoma. A pilot study. Cancer 1990;66:423-30.
16. Chi KH, Chen CH, Chan WK, et al. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil and leucoverin chemotherapy. J Clin Oncol 1995;13:2620-8.
17. Vokes EE, Haraf DJ, Mick R, Mc Evilly JM, Weichselbaum RR. Intensified concomitant chemoradiotherapy with and without filgastrim for poor-prognosis head and neck cancer. J Clin Oncol 1994;12:2351-9.
18. Horiot JC, Le Fur R, N'Guyen T, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992;25:231-41.
19. Datta NR, Choudhry AD, Gupta S, Bose AK. Twice a day versus once a day radiation therapy in head and neck cancer. Proc Am Soc Therap Radiol Oncol 31st Annual Meeting. Int J Radiat Oncol Biol Phys 1989;17:132 (abstr 35).
20. Pinto LH, Canary PCV, Araujo CMM, Bacelar SC, Souhami L. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stage III and IV oropharingeal carcinoma. Int J Radiat Oncol Biol Phys 1991;21:557-62.
21. Marcial V, Pajak T, Chang C, et al. Hyperfractionated radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses using radiation therapy as the only planned modality. Preliminary report by the Radiation Therapy Oncology Group (RTOG). Int J Radiat Oncol Biol Phys 1987;13:41-7.
22. Peters LJ, Ang K. The role of altered fractionation in head and neck cancers. Semin Radiat Oncol 1992;2:180-94.
23. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting result of cancer treatment. Cancer 1981;47:207-14.
24. Armitage P, Berry G. Statistical methods in medical research. Oxford: Blackwell Scientific Publications, 1987.
25. American society of clinical oncology recommendations for the use of hematopoietic colony-stimulating factors: evidence based, clinical practice guidelines. J Clin Oncol 1994;12:2471-508.
26. Asano S. Human granulocyte colony-stimulating factor: its basic aspects and clinical applications. Am J Ped Hematol Oncol 1991;13:400-13.
27. Cox JD, Pajak TF, Marcial VA, et al. Interruption adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory digestive tracts. Cancer 1992;69:2744-84.
28. Levendag PC, Nowak JCM, van der Sangen MJC, et al. Local tumor control in radiation therapy of cancers in the head and neck. Am J Clin Oncol 1996;19(5):469-77.
29. Wang CC, Efird J, Nakfoor B, Martins P. Local control of T3 carcinomas after accelerated fractionation - a look at the gap. Proc Am Soc Therap Radiol Oncol 37th Annual Meeting. Int J Radiat Oncol Biol Phys 1995;32:162 (abstr 43).
30. Maciejewski B, Withers R, Taylor JM, Hliniak A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 2. Normal tissue responses: acute and late effects. Int J Radiat Oncol Biol Phys 1990;18:101-11.
31. Wendt CD, Peters LJ, Ang KK, et al. Hyperfractionated radiotherapy in the treatment of squamous cell carcinoma of the supraglottic larynx. Int J Radiat Oncol Biol Phys 1989;17:1057-62.
32. Bussolino F, Ming Wang JM, Defilippi P, et al. Granulocyte and granulocyte-macrophage colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989;337:471-3.
33. Meropol NJ, Miller LL, Korn EL, Braitman L, Mac Dermott ML, Schucter LM. Severe myelosuppresion resulting from concurrent administration of granulocyte colony stimulating factor and cytotoxic chemotherapy. J Natl Cancer Inst 1992;84:1201-3.